FeesSafety
Pluang+

Exponent reports 18% revenue growth and raises 2026 outlook on strong demand for engineering expertise

Company Fundamentals
29 Oct 2026, 23:05 WIB
GlobeNewsWire
View Source
Bullish
Exponent reports 18% revenue growth and raises 2026 outlook on strong demand for engineering expertise

Exponent, Inc. reported an 18% increase in total revenues to $173.7 million for Q3 2026, driven by strong demand in user research and dispute-related services across multiple industries. Net income rose to $30.9 million, with EBITDA improving to 29.4% of revenues before reimbursements. The company raised its full-year revenue and margin guidance, expecting continued growth fueled by technological innovation and complex client needs. Exponent plans to maintain quarterly dividends and sees a positive long-term growth trajectory amid rising demand for integrated engineering and scientific solutions.

Exponent's third quarter 2026 results show an 18% revenue increase to $173.7 million, with net income rising to $30.9 million. For readers following Industrials-sector stocks, here is Pluang's market snapshot as of Oct 30, 2026 02:31 WIB: out of 135 priced stocks, 100 rose and 34 fell. Notable movers include ADT at USD 9.90 (+33.60%), FTAI at USD 193.88 (+16.00%), and HII at USD 317.00 (+13.51%).

More News

iHerb adds eBay's Jordan Sweetnam to board to boost global eCommerce growth and customer experience.

iHerb adds eBay's Jordan Sweetnam to board to boost global eCommerce growth and customer experience.

iHerb Holdings appointed Jordan Sweetnam, eBay's Chief Commercial Officer, as an independent director to its board. Sweetnam brings extensive experience in global eCommerce, having held senior roles at eBay and Walmart, and will support iHerb's expan...

Company Fundamentals
Bullish
3 hours ago
Alnylam Pharmaceuticals shares drop over 28% after lowering 2026 sales guidance, prompting fraud investigation.

Alnylam Pharmaceuticals shares drop over 28% after lowering 2026 sales guidance, prompting fraud investigation.

Alnylam Pharmaceuticals announced on July 30, 2026, that it lowered its full-year 2026 sales guidance for its TTR product by about $200 million due to slower than expected market growth. This caused the stock to fall 28.31%, injuring investors. On Oc...

Market News
Bearish
4 hours ago
Hyperliquid (HYPE) token rises 3% in an hour, gains 17.28% in 24 hours amid heavy liquidations.

Hyperliquid (HYPE) token rises 3% in an hour, gains 17.28% in 24 hours amid heavy liquidations.

Hyperliquid (HYPE) token price increased by 3.00% within one hour on October 29, reaching $94.82 on Binance. Over the same 24-hour period, HYPE gained 17.28%, reflecting strong upward momentum. During this hour, significant liquidations occurred with...

Market News
Bullish
4 hours ago
Harley-Davidson seen overvalued at 27x P/E with weak earnings and limited growth outlook through 2027.

Harley-Davidson seen overvalued at 27x P/E with weak earnings and limited growth outlook through 2027.

Harley-Davidson is currently trading at a high valuation of 27 times its earnings despite weak operating income and declining sales forecasts projected through 2027. Recent improvements in retail and inventory have not translated into sustainable ear...

Analyst Insights
Bearish
4 hours ago
$5.57B stolen from Binance-linked wallets in possible record crypto hack; investigation ongoing.

$5.57B stolen from Binance-linked wallets in possible record crypto hack; investigation ongoing.

At least $5.57 billion in cryptocurrency was moved out of Binance-linked wallets across Ethereum, Bitcoin, and Tron blockchains in what appears to be a major security breach. Binance has not confirmed a hack but is actively investigating the potentia...

Market News
Bearish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App